Trial Profile
The clinical study on short term continuous subcutaneous insulin infusion combination of sitagliptin and metformin as therapy on newly diagnosed type2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Metformin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Jun 2016 Status changed from not yet recruiting to completed.
- 30 Nov 2013 New trial record